#National Cancer Institute

Women who received a combination of Kisqali and hormone therapy lived twice as long without their cancer getting worse.

Tecentriq (atezolizumab) is the first drug approved approved for advanced alveolar soft part sarcoma, a rare cancer.

Plus: Seven potential harms of cancer screening.

The new director of the National Cancer Institute says her prognosis is very favorable.

Cancer cells with IDH mutations produce an oncometabolite called D-2HG, a molecule that disrupts immune cells’ ability to attack tumors.

Phase I cancer clinical trials are more beneficial for participants than they used to be, says Naoko Takebe, MD, PhD.

A new study identifies a potential approach to prevent mental fog, a common treatment side effect.

Nearly 75% of people with advanced cancer experience breathing problems. Are steroids the best treatment? A new study raises concerns.

Pre-pandemic report shows a modest improvement for survival for people with hard-to-treat pancreatic cancer.

A new study associates physical activity, diet and other healthy lifestyles with a 27% reduction in risk of death for former smokers.

Two studies found a vulnerability in gliomas—a type of brain tumors—that may open the door to new treatments for this cancer.

Cancer researchers analyzed data on half a million tea drinkers. The results suggest health benefits from black tea.

Running was associated with the greatest reduction in risk of cancer deaths, according to a new study. Here are other findings.

People with advanced cancer need fewer hospital visits when they get home care from community health workers.

Researchers found that shutting down the effects of the abnormal collagen made treatments for pancreatic cancer more effective.

Compared with chemotherapy alone, adding immunotherapy drug Keytruda helped triple-negative breast cancer patients live longer.